Among the most exciting discoveries in mitochondrial biology in recent years, MOTS-C has emerged as a uniquely fascinating research compound. Unlike the vast majority of peptides studied in metabolic and longevity science, MOTS-C is not encoded by nuclear DNA — it originates directly from the mitochondrial genome, making it structurally and functionally distinct from almost every other peptide in current research. Since its discovery in 2015, interest has accelerated rapidly and MOTS-C now sits at the intersection of metabolic research, ageing biology, and exercise physiology. This post provides an educational overview of what MOTS-C is and what the current scientific literature tells us. All information is provided strictly for educational and research purposes only.
What Is MOTS-C?
MOTS-C — mitochondrial open reading frame of the 12S rRNA-c — is a 16 amino acid peptide that in humans is encoded by the mitochondrial MT-RNR1 gene. It is believed to be involved in regulating metabolism of glucose by skeletal muscle tissue. It is upregulated in response to exercise and is considered an exercise mimetic. PeptideDeck
MOTS-C is a mitochondrial-derived peptide composed of 16 amino acids encoded by the 12S rRNA region of the mitochondrial genome. The MOTS-C protein is transferred to the nucleus during metabolic stress and directs the expression of nuclear genes to promote cell balance. Different tissues co-express the protein with mitochondria, and plasma also contains the protein, but its level decreases with age. Freemedicaljournals
Discovery and Origins
First identified in 2015, MOTS-C originates directly from the mitochondria, prompting researchers to explore its potential role as an intracellular and endocrine-like signalling molecule involved in cellular energy homeostasis. Since its discovery, interest in MOTS-C research has accelerated rapidly. Scientists are now investigating how this 16 amino acid peptide interacts with key metabolic pathways, including AMPK activation, glucose uptake, and mitochondrial stress response. Blueskieshealthwellness
The discovery was led by a team of researchers at the USC Davis School of Gerontology, opening an entirely new field of mitochondrial-derived peptide research that continues to expand rapidly.
The AMPK Pathway and Glucose Metabolism
One of the most consistently documented findings in MOTS-C research is its activation of the AMPK pathway — a master regulator of cellular energy balance that plays a central role in glucose metabolism, fatty acid oxidation, and mitochondrial biogenesis.
MOTS-C has been shown to improve glucose metabolism in skeletal muscle, indicating its potential relevance for diseases such as diabetes, obesity, and ageing. Muscle cells overexpressing MOTS-C can improve glucose uptake, which is mainly related to the activation of the AMPK pathway. Freemedicaljournals
Studies have discovered that MOTS-C has been shown to significantly reduce the level of pro-inflammatory factors in mice and increase anti-inflammatory factors and insulin-stimulated glucose treatment rates, as well as glucose homeostasis. Human studies showed that exercise increased MOTS-C levels in skeletal muscle and blood circulation, indicating that MOTS-C is a mitochondrial-derived peptide induced by skeletal muscle exercise. NuRev Peptides
Nuclear Translocation — A Unique Mechanism
What makes MOTS-C particularly interesting to researchers is its ability to travel from the mitochondria to the cell nucleus during periods of metabolic stress — a phenomenon known as nuclear translocation.
Studies published in 2023 and 2024 have further clarified the conditions under which MOTS-C moves from mitochondria to the nucleus, identifying stress-responsive nuclear import pathways and specific transcription factor interactions at the nuclear level. Blueskieshealthwellness
This retrograde signalling from mitochondria to nucleus represents a previously unrecognised communication pathway and is one of the reasons MOTS-C has attracted such significant research interest in recent years.
MOTS-C as an Exercise Mimetic
Research provides evidence that late-life initiated intermittent MOTS-C treatment can increase physical capacity and healthspan in mice. In humans, exercise induces endogenous MOTS-C expression in skeletal muscle and in circulation. MOTS-C can regulate nuclear genes including those related to metabolism and proteostasis, skeletal muscle metabolism, and myoblast adaptation to metabolic stress. NiceRx
A particularly active area of MOTS-C research involves its apparent relationship with physical exercise. Studies have found that plasma MOTS-C levels increase in response to acute exercise in human subjects — positioning it as a potential exercise-inducible mitokine. This has opened a line of preclinical inquiry exploring whether exogenous MOTS-C administration can reproduce or enhance metabolic adaptations associated with exercise. Blueskieshealthwellness
Longevity Research
Human studies have found that MOTS-C levels decline with age, and certain genetic variants in the MOTS-C gene sequence correlate with exceptional longevity in centenarian populations. These associations suggest the peptide plays a role in human healthspan and lifespan. John Lee, MD
The level of MOTS-C in skeletal muscle and blood of mice decreases with age. Systemic injection of MOTS-C can restore the level of MOTS-C in aged mice and successfully reverse age-related skeletal muscle insulin resistance. Freemedicaljournals
Diabetes Research
Researchers found that MOTS-C levels decline with ageing in human serum and in publicly available datasets from both humans and mice. The study found that MOTS-C treatment reduced signs of ageing in pancreatic cells and improved their function. MOTS-C treatment improved pancreatic islet senescence and glucose intolerance. In humans, circulating MOTS-C levels are lower in type 2 diabetes patients compared with healthy controls. NiceRx
Cardiovascular Research
MOTS-C treatment restores mitochondrial respiration in type 2 diabetic heart tissue. MOTS-C regulates cellular metabolism through AMPK-dependent pathways, enhancing glucose utilisation and stress responses. Blood MOTS-C levels were reported to be lower in individuals with coronary endothelial dysfunction. Everestregenerative
Mitochondrial Function and Energy Production
MOTS-C appears to enhance mitochondrial efficiency and promote mitochondrial biogenesis — the creation of new mitochondria within cells. Recent studies show it upregulates genes involved in oxidative phosphorylation and antioxidant defence systems. Cells treated with MOTS-C demonstrate higher ATP production capacity and reduced accumulation of reactive oxygen species, which can damage cellular components over time. The peptide also influences fuel substrate selection, helping cells switch between glucose and fatty acid oxidation depending on availability. John Lee, MD
Oncology Research
MOTS-C levels are found to be reduced in both serum and tumour tissues from ovarian cancer patients, which are associated with poor patient prognosis. Exogenous MOTS-C inhibits the proliferation, migration, and invasion of ovarian cancer cells, and induces cell cycle arrest and apoptosis. Swolverine This represents an emerging and particularly compelling area of MOTS-C research that researchers are actively pursuing.
Sex-Specific Research
Some preclinical studies have begun examining whether MOTS-C has sexually dimorphic effects on metabolism, with preliminary data suggesting differential responses in male and female animal models. Blueskieshealthwellness This is an emerging area of investigation that adds further complexity to the MOTS-C research landscape.
Current Research Status
MOTS-C is not approved to treat any medical condition and is banned by the World Anti-Doping Agency, explicitly beginning in 2024. PeptideDeck This WADA classification reflects the compound's recognised activity in skeletal muscle metabolism and physical performance — and underscores why it is exclusively a research compound at this stage of scientific development.
Research Grade MOTS-C from BioSupply UK
BioSupply UK supplies MOTS-C as a research grade compound at 99%+ purity, independently third party lab tested and HPLC verified. Available in 10mg vials with Certificates of Analysis available on request. Strictly for laboratory and in-vitro scientific research only.
This content is provided for educational and research purposes only and does not constitute medical advice. MOTS-C is not approved for human use and should not be used outside of a controlled laboratory research setting.